Sugi Predict

Sugi Predict / Compounds / SCHEMBL13085699

SCHEMBL13085699

SCHEMBL13085699

COc1cc(C(C)C)cc(OC)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ PDE2A O00408 1/20 0.36
▸ FABP3 P05413 1/20 0.35
▸ FABP4 P15090 1/20 0.35
▸ EDNRB P24530 2/20 0.35
▸ EDNRA P25101 2/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21646563 0.87 SMN1; SMN2 (0.35) ALDH1A1KDM4ELMNASMN1; SMN2TDP1
SCHEMBL30147946 0.87 SMN1; SMN2 (0.35) ALDH1A1KDM4ELMNASMN1; SMN2TDP1
SCHEMBL13085710 0.87 POLQ (0.39) ALDH1A1KDM4ELMNASMN1; SMN2L3MBTL1
SCHEMBL12263072 0.85 S1PR2 (0.40) ALDH1A1KDM4ELMNASMN1; SMN2L3MBTL1
SCHEMBL10204250 0.85 SMN1; SMN2 (0.34) ALDH1A1KDM4ELMNASMN1; SMN2TDP1
SCHEMBL13085751 0.80 ALDH1A1 (0.34) ALDH1A1KDM4ELMNASMN1; SMN2TDP1
SCHEMBL20738336 0.80 GAA (0.43) ALDH1A1KDM4ESMN1; SMN2L3MBTL1CYP1A2
SCHEMBL11327071 0.78 ALDH1A1 (0.42) ALDH1A1KDM4ELMNASMN1; SMN2TDP1
SCHEMBL21432271 0.78 ALDH1A1 (0.38) ALDH1A1KDM4ELMNASMN1; SMN2TDP1
SCHEMBL19321644 0.78 NNMT (0.46) ALDH1A1KDM4ELMNATDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129048-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER INC. (US) 2025-04-24 — — US disclosed
WO-2022272060-A1 EP2 ANTAGONIST COMPOUNDS RESERVOIR NEUROSCIENCE, INC. (US) 2022-12-29 — — WO disclosed
US-10807968-B2 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-10-20 — — US disclosed
US-20200048221-A1 SUBSTITUTED 2-(HET)ARYLIMIDAZOLYLCARBOXYAMIDES AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-02-13 — — US disclosed
US-10208024-B2 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases ARRAY BIOPHARMA INC. (US) 2019-02-19 — — US disclosed
US-20170260168-A1 2-ARYL- AND 2-HETEROARYL-SUBSTITUTED 2-PYRIDAZIN-3(2H)-ONE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES ARRAY BIOPHARMA, INC. 2017-09-14 — — US disclosed
US-20170260168-A1 2-ARYL- AND 2-HETEROARYL-SUBSTITUTED 2-PYRIDAZIN-3(2H)-ONE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES ARRAY BIOPHARMA, INC. 2017-09-14 — — US disclosed
WO-2017070708-A1 2-ARYL- AND 2-HETEROARYL-SUBSTITUTED 2-PYRIDAZIN-3(2H)-ONE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES ARRAY BIOPHARMA, INC. (US) 2017-04-27 — — WO disclosed
US-7816522-B2 Triazolone derivatives EISAI CO., LTD. (JP) 2010-10-19 — — US disclosed
US-7807690-B2 2,3-dihydro-iminoisoindole derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-10-05 — — US disclosed
US-7807690-B2 2,3-dihydro-iminoisoindole derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-10-05 — — US disclosed
US-20100184981-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES CLARK RICHARD 2010-07-22 — — US disclosed
US-20090270433-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-10-29 — — US disclosed
US-20090270433-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-10-29 — — US disclosed
US-20080015199-A1 Triazolone derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184981-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES SERPINC1, F7, F2 ALDH1A1 1133/4885KDM4E 2586/4885LMNA 2050/4885
US-20200048221-A1 SUBSTITUTED 2-(HET)ARYLIMIDAZOLYLCARBOXYAMIDES AS PESTICIDES DDT, CYP4X1, CYP4Z1 ALDH1A1 3432/4885KDM4E 231/4885LMNA 1841/4885
US-10807968-B2 Substituted 2-(het)arylimidazolylcarboxyamides as pesticides DDT, CYP4X1, CYP4Z1 ALDH1A1 3432/4885KDM4E 231/4885LMNA 1841/4885
US-10208024-B2 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases FGFR1, FGFR2, FGFR3 ALDH1A1 2575/4885KDM4E 948/4885LMNA 3680/4885
US-20090270433-A1 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES SERPINC1, F7, F2 ALDH1A1 1107/4885KDM4E 2717/4885LMNA 2064/4885
US-20250129048-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF MC4R, MC3R, MC2R ALDH1A1 3955/4885KDM4E 1833/4885LMNA 3693/4885
US-20170260168-A1 2-ARYL- AND 2-HETEROARYL-SUBSTITUTED 2-PYRIDAZIN-3(2H)-ONE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES FGFR1, FGFR2, FGFR3 ALDH1A1 2575/4885KDM4E 948/4885LMNA 3680/4885
US-20080015199-A1 Triazolone derivatives F3, F12, F2 ALDH1A1 710/4885KDM4E 3720/4885LMNA 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.